Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

According to Burkhart, combining a saponin with a TLR agonist has found success before. Biopharma company GSK (formerly GlaxoSmithKline) used the combination in its AS01 adjuvant, in the vaccine ...

The creation of GlaxoSmithKline, forged out of the merger of Glaxo Wellcome ... He talks passionately about the new structure he has pinned his success on. 'At Smith-Kline and Glaxo, we had two very ...

Women in England with a specific type of endometrial cancer will be able to access an immunotherapy for the first time, after NICE backed use of ... The success of clinical trials hinges on ...

It looks like GlaxoSmithKline's concerns about its respiratory ... secure FDA approval – although the jury is out on that. The success of clinical trials hinges on a complex array of factors ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

Seven independent members of the company’s board resigned Tuesday, concluding that despite co-founder and CEO Anne Wojcicki’s ...

New machine learning techniques plumb vast "data lakes" to help researchers design faster, cheaper, more effective clinical ...

In Brentford, around 200 counter-protestors crowded on the corner of a busy junction in the shadow of GlaxoSmithKline ...

Students in the communication program at Drexel take relevant courses that teach them how to become successful public relations ... Exelon Corporation; GlaxoSmithKline; The Philadelphia Inquirer; a ...

The curriculum offers focus and flexibility, allowing students to define their path to success. Graduate students are vigorously ... op positions with a variety of industry leaders, such as ...